Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Colette

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Diabetes Care|February 15, 2008
Glycemic variability: should we and can we prevent it?Louis Monnier, Claude Colette
Current Diabetes Reports|September 10, 2008
Targeting prandial hyperglycemia: how important is it and how best to do this?Louis Monnier, Claude Colette
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Contributions of fasting and postprandial glucose to hemoglobin A1cLouis Monnier, Claude Colette
Expert Opinion on Pharmacotherapy|October 22, 2008
Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T TrialsLouis Monnier, Claude Colette
Diabetes & Metabolism|January 17, 2021
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the "Gordian Knot"?Louis Monnier, Claude Colette, David Owens
Diabetes Care|March 1, 2003
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Louis Monnier, Hélène Lapinski, Claude Colette
Diabetes Technology & Therapeutics|June 15, 2011
Postprandial and basal glucose in type 2 diabetes: assessment and respective impactsLouis Monnier, Claude Colette, David Owens
Diabetes Research and Clinical Practice|November 8, 2011
The glycemic triumvirate and diabetic complications: is the whole greater than the sum of its component parts?Louis Monnier, Claude Colette, David Owens
Journal of Diabetes Science and Technology|November 4, 2009
Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?Louis Monnier, Claude Colette, David R Owens
Diabetes/Metabolism Research and Reviews|May 14, 2009
Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad conceptLouis Monnier, Claude Colette, David R Owens
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Diabetes Care|February 15, 2008
Glycemic variability: should we and can we prevent it?Louis Monnier, Claude Colette
Current Diabetes Reports|September 10, 2008
Targeting prandial hyperglycemia: how important is it and how best to do this?Louis Monnier, Claude Colette
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Contributions of fasting and postprandial glucose to hemoglobin A1cLouis Monnier, Claude Colette
Expert Opinion on Pharmacotherapy|October 22, 2008
Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T TrialsLouis Monnier, Claude Colette
Diabetes & Metabolism|January 17, 2021
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the "Gordian Knot"?Louis Monnier, Claude Colette, David Owens
Diabetes Care|March 1, 2003
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Louis Monnier, Hélène Lapinski, Claude Colette
Diabetes Technology & Therapeutics|June 15, 2011
Postprandial and basal glucose in type 2 diabetes: assessment and respective impactsLouis Monnier, Claude Colette, David Owens
Diabetes Research and Clinical Practice|November 8, 2011
The glycemic triumvirate and diabetic complications: is the whole greater than the sum of its component parts?Louis Monnier, Claude Colette, David Owens
Journal of Diabetes Science and Technology|November 4, 2009
Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?Louis Monnier, Claude Colette, David R Owens
Diabetes/Metabolism Research and Reviews|May 14, 2009
Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad conceptLouis Monnier, Claude Colette, David R Owens
Pageof 3